Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Stine JG, Lewis JH.

Expert Rev Gastroenterol Hepatol. 2016;10(4):517-36. doi: 10.1586/17474124.2016.1127756. Epub 2015 Dec 25. Review.

2.

Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS).

Hoffman KB, Demakas AR, Dimbil M, Tatonetti NP, Erdman CB.

Drug Saf. 2014 Nov;37(11):971-80. doi: 10.1007/s40264-014-0225-0.

3.

Electronic medical record prompts for lab orders in patients initiating statins.

Carroll DG, Alexander C, Radford EA, Leeper J, Carroll DN.

Appl Clin Inform. 2011 Mar 16;2(1):104-15. doi: 10.4338/ACI-2010-07-RA-0044. Print 2011.

4.

Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.

Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC.

Psychiatr Serv. 2013 Apr 1;64(4):339-46. doi: 10.1176/appi.ps.201200147.

5.

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.

Dusetzina SB, Higashi AS, Dorsey ER, Conti R, Huskamp HA, Zhu S, Garfield CF, Alexander GC.

Med Care. 2012 Jun;50(6):466-78. doi: 10.1097/MLR.0b013e318245a160. Review.

6.

Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review.

Fischer SH, Tjia J, Field TS.

J Am Med Inform Assoc. 2010 Nov-Dec;17(6):631-6. doi: 10.1136/jamia.2009.000794. Review.

7.

Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Coleman JJ, McDowell SE, Evans SJ, Gill PS, Ferner RE.

Br J Clin Pharmacol. 2010 Jul;70(1):109-17. doi: 10.1111/j.1365-2125.2010.03654.x.

8.

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Habib ZA, Tzogias L, Havstad SL, Wells K, Divine G, Lanfear DE, Tang J, Krajenta R, Pladevall M, Williams LK.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):437-47. doi: 10.1002/pds.1722.

9.

A randomized trial of electronic clinical reminders to improve medication laboratory monitoring.

Matheny ME, Sequist TD, Seger AC, Fiskio JM, Sperling M, Bugbee D, Bates DW, Gandhi TK.

J Am Med Inform Assoc. 2008 Jul-Aug;15(4):424-9. doi: 10.1197/jamia.M2602. Epub 2008 Apr 24.

10.

Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R.

J Gen Intern Med. 2005 Dec;20(12):1120-6.

11.

The effect of automated alerts on provider ordering behavior in an outpatient setting.

Steele AW, Eisert S, Witter J, Lyons P, Jones MA, Gabow P, Ortiz E.

PLoS Med. 2005 Sep;2(9):e255. Epub 2005 Sep 6.

12.

Laboratory safety monitoring of chronic medications in ambulatory care settings.

Hurley JS, Roberts M, Solberg LI, Gunter MJ, Nelson WW, Young L, Frost FJ.

J Gen Intern Med. 2005 Apr;20(4):331-3.

13.

Balancing commercial and public interests.

Furberg CD, Hall MA, Sevick MA.

Curr Control Trials Cardiovasc Med. 2004 Jul 7;5(1):6.

14.

Supplemental Content

Support Center